HOLLAND & KNIGHT LLP

Lobbying for ALVOTECH SA · Biosimilar medicine development and manufacture

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 17, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Lobbying activity 1

Trade (domestic/foreign)

Trade policy and tariff impacts on the pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.